| 000 | 01657 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516062817.0 | ||
| 264 | 0 | _c20120412 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2011.04908.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZachou, K | |
| 245 | 0 | 0 |
_aAnti-α actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cJan 2012 |
||
| 300 |
_a116-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aActinin _ximmunology |
| 650 | 0 | 4 |
_aActins _ximmunology |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis, Autoimmune _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aOikonomou, K | |
| 700 | 1 | _aRenaudineau, Y | |
| 700 | 1 | _aChauveau, A | |
| 700 | 1 | _aGatselis, N | |
| 700 | 1 | _aYouinou, P | |
| 700 | 1 | _aDalekos, G N | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 35 _gno. 1 _gp. 116-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2011.04908.x _zAvailable from publisher's website |
| 999 |
_c21280254 _d21280254 |
||